SCHEMBL27969312

SCHEMBL27969312

CC1(c2ncc(CN=[N+]=[N-])s2)OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27863967 0.77 — —
SCHEMBL854974 0.75 — —
SCHEMBL1166831 0.75 ALDH1A1 (0.31) —
SCHEMBL855655 0.75 CYP2A6 (0.30) —
SCHEMBL15103630 0.75 KAT2B (0.32) —
SCHEMBL14279802 0.72 SLC6A3 (0.36) —
SCHEMBL1705840 0.71 SMN1; SMN2 (0.33) —
SCHEMBL18641539 0.70 CYP1A2 (0.40) —
SCHEMBL21273270 0.69 PDE10A (0.31) —
SCHEMBL17080194 0.69 KAT2B (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102414168-B Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists ACTELION PHARMACEUTICALS LTD 2014-05-21 — — CN disclosed
Send feedback